Despite millions of cases of norovirus in the U.S. each year—and a current surge in outbreaks—there is still no vaccine for ...

We don’t have answers for all the deadly infectious diseases in the world, a fact made painfully clear Monday as Louisiana ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

The Centers for Disease Control and Prevention (CDC) has selected University of California San Diego as one of three partner institutions to establish a groundbreaking pandemic preparedness initiative ...

And now, the human metapneumovirus, or HMPV for short, is infecting thousands of Americans around the country. The highly ...

The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...

The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...

Directed to investigate possible wrongdoing related to COVID-19 vaccines, a statewide grand jury released a report Tuesday ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

For the week ending Saturday, Jan. 4, COVID-19 accounted for 1.6% of all emergency department visits in Virginia, with ...